Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Artificial Intelligence in Chronic Lymphocytic Leukemia: From Prognostic Biomarkers to Individualized Treatment Selection.

Created on 14 Nov 2026

Authors

Bogdana Ghimpău, Sandra Timar, Dacian Nicolae Oros, Alexia Ioniță, Despina Calamar-Popovici, Ramona Cioacă, Ioana Ioniță

Published in

Diagnostics (Basel, Switzerland). Volume 16. Issue 21. Oct 27, 2026. Epub Oct 27, 2026.

Abstract

Available artificial intelligence (AI) applications in chronic lymphocytic leukemia (CLL) mainly address diagnosis, prognosis, treatment need, or measurable residual disease rather than comparative treatment selection. This state-of-the-art review examines the gap and proposes a CLL-specific clinical decision-support architecture. A focused evidence map was assembled by title-and-abstract screening of 245 unique PubMed records retrieved using a documented 2014-September 2026 search strategy. Fifty-five original CLL-relevant AI and machine learning (ML) reports were retained for descriptive mapping. Existing tools are heterogeneous and rarely establish comparative causal effects under competing regimens. We define individualized selection using clinically eligible treatment sets, explicit treatment contrasts, regimen-specific outcomes, calibration and uncertainty checks, and post hoc longitudinal patient-preference filtering. The architecture is conceptual, not a trained or externally validated treatment-selection algorithm; prospective studies will be necessary to demonstrate clinical utility.

PMID:
43028395
Bibliographic data and abstract were imported from PubMed on 14 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 4
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement